Stuart Roberts, Life Sciences Analyst at NDF Research, discusses Mesoblast, and what the market has wrong about it.
Livewire gives investors direct access to the stock ideas, research and exclusive insights of hundreds of Australia’s leading investment professionals. To access more exclusive market content and to receive the top three insights each day, register for FREE at [ Ссылка ]
Disclaimer: The information contained in this presentation is general in nature and should not be relied upon. Before making any investment or planning decisions, you should consult a licensed professional who can advise you whether your decision is appropriate for you. Contributors to this show may have commercial or financial interests in the companies mentioned.
Ещё видео!